Immunotherapy Emerging in HCC – Targeted Oncology
Targeted Oncology |
Immunotherapy Emerging in HCC
Targeted Oncology In an interview with Targeted Oncology at the ILC, Tim F. Greten, MD, senior investigator, Thoracic and Gastrointestinal Oncology Branch, head, Gastrointestinal Malignancy Section, the National Cancer Institute, discussed the evolving role of … |
